The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin

Emerging evidence suggests that dipeptidyl peptidase-4 (DPP-4) inhibitors used to treat type 2 diabetes may have nephroprotective effects beyond the reduced renal risk conferred by glycemic control. DPP-4 is a ubiquitous protein with exopeptidase activity that exists in cell membrane-bound and solub...

Descripción completa

Detalles Bibliográficos
Autor principal: Kanasaki, Keizo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2018
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828949/
https://www.ncbi.nlm.nih.gov/pubmed/29491123
http://dx.doi.org/10.1042/CS20180031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828949/
https://www.ncbi.nlm.nih.gov/pubmed/29491123
http://dx.doi.org/10.1042/CS20180031

Ejemplares similares